Envoy Medical
COCH
27 hedge funds and large institutions have $1.01M invested in Envoy Medical in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
4% less funds holding
Funds holding: 28 → 27 (-1)
4.6% less ownership
Funds ownership: 9.87% → 5.27% (-4.6%)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
39% less capital invested
Capital invested by funds: $1.65M → $1.01M (-$641K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$94.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$70K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$41K |
| 4 |
Corient Private Wealth
Miami,
Florida
|
+$30.2K |
| 5 |
ACP
Arcus Capital Partners
Atlanta,
Georgia
|
+$27.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AMC
Atlas Merchant Capital
New York
|
-$431K |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$188K |
| 3 |
DCA
DSG Capital Advisors
Edina,
Minnesota
|
-$127K |
| 4 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$30K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$20.5K |
COCH Hedge Fund Activity: Q4 2025 in Review
27 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2025, worth a combined $1.01M — down 39% from $1.65M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of COCH and 6 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 9 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $94.3K. The largest seller was Atlas Merchant Capital, exiting entirely with an estimated $431K sold.
- 27 institutional investors held Envoy Medical (COCH) as of Q4 2025, down from 28 in Q3 2025.
- Funds reported $1.01M of Envoy Medical stock for Q4 2025, down 39% quarter-over-quarter.
- 6 funds opened new Envoy Medical positions in Q4 2025 and 7 closed out, a net change of -1 holder.
- The largest Envoy Medical buyer in Q4 2025 was Susquehanna International Group, an estimated $94.3K added.
- The largest Envoy Medical seller in Q4 2025 was Atlas Merchant Capital, an estimated $431K sold.
Based on aggregated 13F filings for Q4 2025.